DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Jevtana (Cabazitaxel) - Current Clinical Trials

 
 



Jevtana Related Clinical Trials

Cabazitaxel - PF Induction Chemotherapy [Completed]

Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU) [Recruiting]

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer [Withdrawn]

Study of Weekly Cabazitaxel for Advanced Prostate Cancer [Active, not recruiting]

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer [Recruiting]

Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy [Active, not recruiting]

Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer [Terminated]

Phase I/II Cabazitaxel for Recurrent Malignant Glioma [Withdrawn]

Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor [Terminated]

Study of the Effect of Chemotherapy With Cabazitaxel on Prostate Cancer [Recruiting]

A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse [Recruiting]

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy [Active, not recruiting]

Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Hormone-Resistant Prostate Cancer [Recruiting]

Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases [Recruiting]

Ph II Cabazitaxel/Ifosfamide DD Liposarcoma [Recruiting]

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer [Recruiting]

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer [Recruiting]

Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment [Terminated]

A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC) [Completed]

Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer [Recruiting]

The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation [Withdrawn]

Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors [Recruiting]

Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer [Active, not recruiting]

Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC [Withdrawn]

Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes [Recruiting]

A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer [Completed]

Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer [Active, not recruiting]

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors [Completed]

A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer [Recruiting]

Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel [Recruiting]

Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel [Withdrawn]

Bristol Bladder Trial [Recruiting]

CLUBNET-CABAZ_L_06639 Neoadjuvant Chemotherapy With Cabazitaxel [Recruiting]

Cabazitaxel and Radiation For Patients With Pathologically Determined Stage 3 Prostate Cancer and/or Patients With PSA Elevation (>0.1- < 2.0 ng/mL) [Terminated]

Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel [Terminated]

XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer [Completed]

A Study of Cabazitaxel for Patients With Breast or Lung Cancer and Recurrent or Progressive Brain Metastases - Cabazitaxel for Brain Metastases (CaBaMet) [Not yet recruiting]

Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma [Active, not recruiting]

Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enz [Recruiting]

Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent [Not yet recruiting]

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen [Completed]

Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen [Terminated]

Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer [Completed]

Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment [Completed]

Cabazitaxel in Relapsed and Metastatic NSCLC [Active, not recruiting]

Effect of Cabazitaxel on the QTc Interval in Cancer Patients [Completed]

Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer [Active, not recruiting]

Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer [Recruiting]

Cabazitaxel in Platinum Refractory Ovarian Cancer [Terminated]

Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer [Completed]

Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer [Recruiting]

Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer [Recruiting]

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA [Terminated]

Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Completed]

Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy [Completed]

A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors [Recruiting]

Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer [Active, not recruiting]

Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer [Active, not recruiting]

A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes [Active, not recruiting]

Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancer [Completed]

Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer [Completed]

Efficacy and Safety of Cabazitaxel Versus Weekly Paclitaxel as Neo-adjuvant Treatment in Patients With Triple Negative or Luminal B/HER2 Normal BC (GENEVIEVE) [Recruiting]

Efficacy Study Evaluating Chemotherapy in Prostate Cancer [Recruiting]

The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer [Active, not recruiting]

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors [Active, not recruiting]

PROSTAC: Multicentre Biomarker Study in CRPC Treated With Chemotherapy [Recruiting]

Second-line Chemotherapy in Castration Resistant Prostate Cancer [Recruiting]

Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T [Recruiting]

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) [Terminated]

Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate [Recruiting]

A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC) [Completed]

GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer [Completed]

Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer [Not yet recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017